Register for SOSV’s VC-Founder Physical AI Matchup – May 11-15
Back
IndieBio New York’s Investor Showcase – March 11, 2026
Back
Supriya Agarwal
Supriya Agarwal
February 2, 2026

Join us for an exclusive investor showcase on March 11, 2026 featuring Pre-Seed, Seed, and Series A companies from IndieBio NY’s portfolio—all working to advance human and planetary health.

This event reflects IndieBio NY’s core strength: derisking biology and business. Many teams are already revenue-touching, in-clinic, or scaling early customers, and all are operating at meaningful inflection points across Seed and Series A.

Here are the links to register:

  • In-Person, Investors only – 2:00-5:00 PM ET  Register
  • Virtual, Investors only – 5:00 PM ET Register

You’ll meet teams building breakthrough solutions across the following categories:

AI + Biology

Engineered Biology and Biomaterials

Consumer Biology

  • ​Sable Therapeutics (Pre-Revenue) – Topical approach to localized fat loss
  • ​​Janus (Pre-Revenue) – Neuro-AI insights into pet health
  • ​​5h45 (Pre-Revenue) – Biomaterials redefining hair care
  • ​Harmony (Pre-Revenue) – Human-inspired hypoallergenic baby formula

New Therapeutic Modalities

  • ​​​Anomer Bio (Discovery) – Synthetic sugars modulating immunity & fibrosis
  • ​Circadian OS (Clinical Stage) – Circadian reprogramming for cancer treatment
  • ​​Moonlight Therapeutics (Clinical Stage) – Immune retraining for allergies
  • ​Hexembio (Pre-Clinical) – Rejuvenating human blood cells for improved healthspan
  • ​Cayuga Biotech (Clinical Stage) – Biomimetic solutions for hemorrhage control

Seats are limited. Register now to secure your spot.

After the pitches, investors can mingle with founders and fellow investors while enjoying light refreshments.

Questions? Email us at events@sosv.com

Did you know?

How Ten63 turned an academic project into an AI platform for drugging “undruggable” cancers

Bruce Donald, Marcel Frenkel and Mark Hallen are analyzing over 19,290,123 compounds per second at quantum accuracies to develop drugs to previously incurable cancers.

unspun’s Weaving Machines Aim to Fix Apparel’s Waste and Carbon Problem

Funded with $57 million from DCVC, Lowercarbon Capital and SOSV, among others, unspun aims to eliminate 1% of global carbon emissions

NotCo’s plant-based foods are on store shelves, but its AI engine “Giuseppe” is the real business

While it might look like a plant-based food company, NotCo is in the data and AI business—and aims to disrupt R&D in many industries that use animal and plant ingredients.

Smartex is Creating the Textile Factory of the Future

Gilberto Loureiro grew up inspecting fabrics in a Portuguese textile factory. With Smartex, he and co-founders Antonio Rocha and Paulo Ribeiro are eliminating textile defects—and their enormous cost both to manufacturers and the environment.

Novoloop Is Upcycling Your Future

Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.

Upside Foods Serves Up a Sustainable Future

To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.

Sleeping Beauty

In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.

The Loneliness of the Long-Distance Entrepreneur

In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.

Chiu Chau Reboots a Robot into a Billion Dollar Business

It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.

RxAll’s Life-Saving Deep Tech for African Pharmacies

Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.